cardiovascular
Research shows Novartis’s Entresto reduces cardiovascular death and heart failure
April 4, 2016Research and Development, Sales and Marketing Entresto, Novartis, Regeneron, Sanofi, cardiovascular, clinical trial, patent
Novartis has announced results from the PARADIGM-HF clinical trial that show that Entresto (sacubitril/valsartan) consistently demonstrated benefit among heart failure …
Crown Bioscience expands portfolio with PreClinOmics acquisition
March 9, 2016Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics
Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …
AZ and Takeda diabetes drugs get FDA safety update
April 15, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin
An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …
AstraZeneca diabetes drug could ‘significantly’ increase mortality
April 13, 2015Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin
AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …
AstraZeneca and Harvard team up for diabetes research
March 25, 2015Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic
AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …
Sanofi and Boehringer partner on biologics manufacturing
January 15, 2015Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology
Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …
AstraZeneca signs Vodafone contract
March 20, 2014Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone
AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …
Merck signs Theravance cardio deal
October 19, 2012Sales and Marketing Merck, Theravance, cardiovascular
Merck has signed a deal with US biopharma firm Theravance to discover and develop novel small molecules to treat cardiovascular …
Roche abandons Phase III cholesterol drug
May 8, 2012Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure
Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
BMS in cholesterol alliance with China’s Simcere
December 16, 2011Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets
Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …
Takeda’s blood pressure treatment Edarbi approved
December 9, 2011Sales and Marketing Diovan, Eisai, cardiovascular, high blood pressure, hypertension
Takeda’s new hypertension treatment Edarbi has been approved in Europe.Edarbi (azilsartan medoxomil) is a new once-daily angiotensin receptor blocker (ARB) …
Health secretary calls for global action on lifestyle conditions
September 21, 2011cardiovascular, diabetes, respiratory, smoking
Health secretary Andrew Lansley has urged governments across the world to be “bold and determined” in working together to tackle …
Vytorin cuts heart problems in kidney patients
November 23, 2010Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
